Management of neonatal herpes simplex virus infections

Indian Journal of Pediatrics

Volumn 71, Issue 10, 2004, Pages 921-926

  Freij, Bishara J ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Acyclovir; Cesarean section; Herpes encephalitis; Herpes simplex virus; Pregnancy complications infectious

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; IDOXURIDINE; IMMUNOGLOBULIN; TRIFLURIDINE; VALACICLOVIR; VIDARABINE; VIRUS DNA;

CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CESAREAN SECTION; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC TEST; EXPOSURE; EYE INFECTION; GENITAL HERPES; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; INTRAUTERINE INFECTION; MORTALITY; MUCOSA; NEUROIMAGING; NEUTROPENIA; NEWBORN INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; TERATOGENICITY; VIRUS CULTURE; VIRUS DETECTION; VIRUS ISOLATION;

EID: 9644259358     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02830837     Document Type: Conference Paper

References (32)

1. Armstrong GL, Schillinger J, Markowitz L et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001; 153: 912-920.
2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002; 51(RR-6): 1-78.
3. Brown ZA, Selke S, Zeh J et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337: 509-515.
4. Fleming DT, McQuillan GM, Johnson RE et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-1111.
5. Kaur R, Gupta N, Nair D, Kakkar M, Mathur MD. Screening for TORCH infections in pregnant women: a report from Delhi. Southeast Asian J Trop Med Public Health 1999; 30: 284-286.
6. Cowan FM, French RS, Mayaud P et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect 2003; 79: 286-290.
7. Jonsson MK, Wahren B. Sexually transmitted herpes simplex viruses. Scand J Infect Dis 2004; 36: 93-101.
8. Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 2000; 45: 1-8.
9. Kimberlin DW, Rouse DJ. Genital herpes. N Engl J Med 2004; 350: 1970-1977.
10. Wald A, Zeh J, Selke S et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342: 844-850.
11. Kimberlin DW, Lin C-Y, Jacobs RF et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108: 223-229.
12. Freij BJ, Sever JL. Fetal herpes simplex virus infection. In Buyse ML, ed. Birth Defects Encyclopedia. Boston; Blackwell Scientific Publications, 1990; 713-714.
13. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17: 1-13.
14. Filippine MM, Katz BZ. Neonatal herpes simplex virus infection presenting with fever alone. J Hum Virol 2001; 4: 223-225.
15. Toth C, Harder S, Yager J. Neonatal herpes encephalitis: a case series and review of clinical presentation. Can J Neurol Sci 2003; 30: 36-40.
16. Kimura H, Futamura M, Ito Y et al. Relapse of neonatal herpes simplex virus infection. Arch Dis Child Fetal Neonatal Ed 2003; 88: F483-F486.
17. Whitley R, Arvin A, Prober C et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991; 324: 450-454.
18. th ed. Washington, DC; ASM Press, 2003; 1291-1303.
19. Kimura H, Ito Y, Futamura M et al. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol 2002; 67: 349-353.
20. Whitley R, Arvin A, Prober C et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991; 324: 444-449.
21. Kimberlin DW, Lin C-Y, Jacobs RF et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108: 230-238.
22. Pramod NP, Thyagarajan SP, Mohan KVK, Anandakannan K. Acyclovir resistance in herpes simplex virus isolates from keratitis cases: an analysis from a developing country. Microbiol Immunol 2000; 44: 241-247.
23. Nyquist A-C, Rotbart HA, Cotton M et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr 1994; 124: 967-971.
24. Kesson AM. Management of neonatal herpes simplex virus infection. Pediatr Drugs 2001; 3: 81-90.
25. Reynolds SJ, Risbud AR, Shepherd ME et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Inject Dis 2003; 187: 1513-1521.
26. Leonard JR, Moran CJ, Cross DT III, Wippold FJ II, Schlesinger Y, Storch GA. MR imaging of herpes simplex type 1 encephalitis in infants and young children: a separate pattern of findings. AJR Am J Roentgenol 2000; 174: 1651-1655.
27. Kimberlin D, Powell D, Gruber W et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996; 15: 247-254.
28. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 68: 165-173.
29. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203-209.
30. Garland SM, Lee TN, Sacks S. Do antepartum herpes simplex virus cultures predict intrapartum shedding for pregnant women with recurrent disease? Infect Dis Obstet Gynecol 1999; 7: 230-236.
31. Sheffield JS, Kollier LM, Hill JB, Stuart GS, Wendel GD Jr. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003; 102: 1396-1403.
32. Centers for Disease Control and Prevention. Pregnancy outcomes following systemic prenatal acyclovir exposure - June 1, 1984-June 30, 1993. MMWR 1993; 42: 806-809.